nach oben

World Journal of Urology

Erschienen in:

18.12.2017 | Letter to the Editor

Letter to the Editor: A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy

verfasst von: Christopher Netsch, A. J. Gross

Erschienen in: World Journal of Urology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Excerpt

We thank the author for his comment on the early results of our prospective randomized controlled trial (RCT) comparing thulium vapoenucleation of the prostate (ThuVEP) with holmium laser enucleation of the prostate (HoLEP) for the treatment of benign prostatic obstruction (BPO) [1]. HoLEP has been proven in numerous randomized controlled trials (RCT) to be a minimally-invasive, size-independent method with excellent long-term results [2], but the evidence for alternative techniques mimicking the HoLEP technique is rather limited. In the current prospective RCT we compared the established HoLEP technique with the alternative ThuVEP technique [1]. …

Netsch C, Becker B, Tiburtius C, Moritz C, Becci AV, Herrmann TR, Gross AJ (2017) A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy. World J Urol 11:1–9

Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H, Madersbacher S (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67:1066–1096CrossRefPubMed

Bach T, Muschter R, Sroka R, Gravas S, Skolarikos A, Herrmann TR, Bayer T, Knoll T, Abbou CC, Janetschek G, Bachmann A, Rassweiler JJ (2012) Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol 61:317–325CrossRefPubMed

Zhu L, Chen S, Yang S, Wu M, Ge R, Wu W, Liao L, Tan J (2013) Electrosurgical enucleation versus bipolar transurethral resection for prostates larger than 70 ml: a prospective, randomized trial with 5-year followup. J Urol 189:1427–1431CrossRefPubMed

Netsch C, Becker B, Tiburtius C, Moritz C, Venneri Becci A, Herrmann T, Gross A (2017) Thulium vapoenucleation of the prostate versus holmium laser enucleation of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a prospective randomized trial. Eur Urol Suppl 16(3):e512–e513CrossRef

Neill MG, Gilling PJ, Kennett KM, Frampton CM, Westenberg AM, Fraundorfer MR, Wilson LC (2006) Randomized trial comparing holmium laser enucleation of prostate with plasmakinetic enucleation of prostate for treatment of benign prostatic hyperplasia. Urology 68:1020–1024CrossRefPubMed

El-Hakim A, Elhilali MM (2002) Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int 90:863–869CrossRefPubMed

Shah HN, Mahajan AP, Sodha HS, Hegde S, Mohile PD, Bansal MB (2007) Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol 177:1468–1474CrossRefPubMed

Netsch C, Bach T, Herrmann TR, Neubauer O, Gross AJ (2013) Evaluation of the learning curve for thulium vapoenucleation of the prostate (ThuVEP) using a mentor-based approach. World J Urol 31:1231–1238CrossRefPubMed

10.

Gross AJ, Netsch C, Knipper S, Hölzel J, Bach T (2013) Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol 63:859–867CrossRefPubMed

11.

Comat V, Marquette T, Sutter W, Bernhard JC, Pasticier G, Capon G, Bensadoun H, Ferrière JM, Robert G (2017) Day-case holmium laser enucleation of the prostate: prospective evaluation of 90 consecutive cases. J Endourol 31:1056–1061CrossRefPubMed

12.

https://www.smartpatients.com/trials/NCT02737241 (trial NCT02737241, Mans 26-11-2015)

Titel: Letter to the Editor: A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy
verfasst von: Christopher Netsch
A. J. Gross
Publikationsdatum: 18.12.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 3/2018
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-017-2158-6

Neu im Fachgebiet Urologie

25.04.2024 | Nierenkarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Letter to the Editor: A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy

Excerpt

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis

Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting

Comparison of readmission and short-term mortality rates between different types of urinary diversion in patients undergoing radical cystectomy

A single mitochondrial DNA deletion accurately detects significant prostate cancer in men in the PSA ‘grey zone’

Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis

PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie